Chairman, President and Chief Executive Officer , Merck & Co., Inc.
Kenneth C. Frazier is Chairman, President and Chief Executive Officer of Merck & Co., Inc.
Previously, Ken served as president of Merck, with responsibility for the company’s three major divisions: Global Human Health, Merck’s pharmaceutical and vaccine business; Merck Manufacturing Division, Merck’s manufacturing and supply division; and Merck Research Laboratories, Merck’s research organization.
Ken has held a broad range of senior management positions since joining Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group. He was elected vice president of public affairs in 1994 and in 1997, assumed the additional responsibilities of assistant general counsel, corporate staff. Ken was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In this role, he oversaw Merck’s legal and public affairs functions and The Merck Company Foundation. In November 2006, he was promoted to executive vice president and general counsel. Ken served as executive vice president and president, Global Human Health, from 2007 to May 2010, when he became Merck president.
Before joining Merck, Ken was a partner with the Philadelphia firm of Drinker Biddle & Reath. Ken sits on the boards of Exxon Mobil Corporation, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA. Ken also is a member of the Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.
Ken received his bachelor’s degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.